Mission

You probably don’t have to look far to know someone who has been diagnosed with cancer. Every second child born today will be diagnosed with the disease sometime during their lifetime and 7 million Americans will die from it this year. At Protox, our hard work and dedication is driven by the belief that behind every statistic is a life and behind every estimate, hope. Our mission is to change these statistics for the better as we focus on developing and commercializing engineered protein toxins for the treatment of cancer and other proliferative diseases.

What's New

February 25, 2010
Protox Revises Terms Of Private Placement

February 24, 2010
Protox To Present At The Third International Symposium On Focal Therapy And Imaging Of Prostate And Kidney Cancer

February 4, 2010
Protox Announces Private Placement

January 11, 2010
Protox Announces Positive Phase 2B BPH Results

 

 

Events

January 11, 2010 - 8:45 am ET
Protox Therapeutics Conference Call - Webcast Link

 

Stock Quote

LAST TRADE:$0.435
TRADE TIME:1:44PM EST
CHANGE:$0.00 (0.00%)
PREV CLOSE: $0.435
OPEN:$0.435
BID:$0.435
ASK:$0.445